News
Season’s Greetings from EPHMRA!
Firstly, we want to take a moment to thank each and every one of our valued members for their dedication, collaboration, and contributions throughout the year.
We wish you all a great Festive Season and hope you are able to enjoy some time with family and friends.
Looking forward to reconnecting again in 2025.
EPHMRA Webinar
This session aims to teach you how to plan and deliver high impact virtual debriefs and presentations.
April 30 2024 @ 14.00 – 15.30 UK time
Speaker: Caroline Florence, Insight Narrator Ltd
Convenors: Marcel Slavenburg, SKIM and Alexander Rummel, Aurum Research GmbH – both LDC members
This is your final call for synopses for the 2024 Basel Chapter meeting!
The submission deadline is 30 April!
‘Analysing the impact of Health Inequality: Unravelling the Business Question’
Meeting Convenors:
Ana Maria Aguirre-Arteta, Novartis
Angela Duffy, Research Partnership
Doing Market Research in Mexico
May 28 2024
15.00 – 15.45 UK time
Speaker: Simeon Pickers ♠️, Psyma
Members only 90-minute online training session will teach you how to plan and deliver high impact virtual debriefs and presentations.
April 30 2024 @ 14.00 – 15.30 UK time
Speaker: Caroline Florence, Insight Narrator Ltd
2024 Conference Grant Winners announced!
There were 25 applications for the 5 free conference grants and the winners were:
Melissa Lehmann, impulze GmbH
Join us at the 2024 EPHMRA Conference and hear about the paper...
'Understanding doctors as people to fuel insights-driven omnichannel strategy and personalised engagement'
From speakers - Elena Brutto (ex. Geatches) and Tasleem Rehmatullah, The Nursery Research & Planning.
Great to see everyone in Berlin yesterday at our 2024 Germany One-Day chapter meeting!
What can we say - great papers, great discussions and everyone enjoyed meeting up.
Send in your Synopsis for the 2024 Basel meeting on 19 September Submission deadline is 30 April ‘Analysing the impact of Health Inequality: Unravelling the Business Question’
Meeting Convenors:
Ana Maria Aguirre-Arteta, Novartis
Angela Duffy, Research Partnership
Fenna Gloggner, Idorsia Pharmaceuticals
Hannah Osborn, Pure Healthcare Strategy